TRANSFAC-Logo

TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN


AC T01302 XX ID T01302 XX DT 21.10.1994 (created); ewi. DT 13.08.2015 (updated); jmh. CO Copyright (C), QIAGEN. XX FA GATA-2 XX SY GATA-2; NF-E1b (chick). XX OS mouse, Mus musculus OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; rodentia; myomorpha; muridae; murinae XX GE G005726 Gata2. XX CL C0004; CC; 2.2.1.1.2. XX SF all sequences outside the C-terminal zinc finger are partially dispensable for megakaryocytic differentiation [3]; XX CP pluripotent hematopoietic stem cells [5]. XX FF GATA-2 knock-out mice die by embryonic days 10-11 due to defects in hematopoiesis [6]; FF GATA-2 induces megakaryocytic differentiation [3]; FF GATA-2-transfected embryonal stem cells do not express the surface receptors c-kit, flt-3 and CD34 (in contrast to c-Myb-transfected ones T00138) [4]; FF c-Myb T00138 and GATA-2 act independently of each other on hematopoiesis [4]; FF IL-3 stimulation of hematopoietic progenitor cells (BA/F3 0752) leads to MAP kinase-dependent hyper-phosphorylation of GATA-2 [2]; FF cooperates with PU.1 to provide mast cell differentiation [8]; FF regulator of the vascular development, together with SCL/Tal-1 and Ets factors [9]; XX IN T08464 C/EBPalpha; mouse, Mus musculus. IN T00305 GATA-1; mouse, Mus musculus. IN T02235 PEBP2alphaB1; mouse, Mus musculus. IN T01516 Pit-1B; rat, Rattus norvegicus. IN T09976 PU.1; human, Homo sapiens. XX MX M00076 V$GATA2_01. MX M00348 V$GATA2_02. MX M00349 V$GATA2_03. MX M01877 V$GATA2_Q5. MX M00203 V$GATA_C. MX M00789 V$GATA_Q6. XX BS R71266. BS R73536. BS R71577. BS R71478. BS R71479. BS R71480. BS R71481. BS R71482. BS R33239. BS R14469. BS R69239. BS R03884. BS R21046. BS R71259. BS R23089. BS R23092. BS R14425. BS R20583. BS R59415. BS R37952. XX DR TRANSPATH: MO000025566. DR TRANSCOMPEL: C00519. DR TRANSCOMPEL: C00603. DR UniProtKB: O09100; XX RN [1]; RE0001072. RX PUBMED: 1744088. RA Zon L. I., Gurish M. F., Stevens R. L., Mather C., Reynolds D. S., Austen K. F., Orkin S. H. RT GATA-binding transcription factors in mast cells regulate the promoter of the mast cell carboxypeptidase A gene RL J. Biol. Chem. 266:22948-22953 (1991). RN [2]; RE0011615. RX PUBMED: 7876160. RA Towatari M., May G. E., Marais R., Perkins G. R., Marshall C. J., Cowles S., Enver T. RT Regulation of GATA-2 phosphorylation by mitogen-activated protein kinase and interleukin-3 RL J. Biol. Chem. 270:4101-4107 (1995). RN [3]; RE0013447. RX PUBMED: 7823932. RA Visvader J. E., Crossley M., Hill J., Orkin S. H., Adams J. M. RT The C-terminal zinc finger of GATA-1 or GATA-2 is sufficient to induce megakaryocytic differentiation of an early myeloid cell line. RL Mol. Cell. Biol. 15:634-641 (1995). RN [4]; RE0013449. RX PUBMED: 8643572. RA Melotti P., Calabretta B. RT The transcription factors c-myb and GATA-2 act independently in the regulation of normal hematopoiesis. RL Proc. Natl. Acad. Sci. USA 93:5313-5318 (1996). RN [5]; RE0013450. RX PUBMED: 7538677. RA Orlic D., Anderson S., Biesecker L. G., Sorrentino B. P., Bodine D. M. RT Pluripotent hematopoietic stem cells contain high levels of mRNA for c-kit, GATA-2, p45 NF-E2, and c-myb and low levels or no mRNA for c-fms and the receptors for granulocyte colony-stimulating factor and interleukins 5 and 7. RL Proc. Natl. Acad. Sci. USA 92:4601-4605 (1995). RN [6]; RE0013451. RX PUBMED: 8078582. RA Tsai F.-Y., Keller G., Kuo F. C., Weiss M., Chen J., Rosenblatt M., Alt F. W., Orkin S. H. RT An early haematopoietic defect in mice lacking the transcription factor GATA-2. RL Nature 371:221-226 (1994). RN [7]; RE0013568. RX PUBMED: 9452491. RA Minegishi N., Ohta J., Suwabe N., Nakauchi H., Ishihara H., Hayashi N., Yamamoto M. RT Alternative promoters regulate transcription of the mouse GATA-2 gene. RL J. Biol. Chem. 273:3625-3634 (1998). RN [8]; RE0023175. RX PUBMED: 12433372. RA Walsh J. C., DeKoter R. P., Lee H.- J., Smith E. D., Lancki D. W., Gurish M. F., Friend D. S., Stevens R. L., Anastasi J., Singh H. RT Cooperative and antagonistic interplay between PU.1 and GATA-2 in the specification of myeloid cell fates. RL Immunity 17:665-676 (2002). RN [9]; RE0023734. RX PUBMED: 11049987. RA Kappel A., Schlaeger T. M., Flamme I., Orkin S. H., Risau W., Breier G. RT Role of SCL/Tal-1, GATA, and ets transcription factor binding sites for the regulation of flk-1 expression during murine vascular development. RL Blood 96:3078-3085 (2000). RN [10]; RE0036169. RX PUBMED: 15632071. RA Tong Q., Tsai J., Tan G., Dalgin G., Hotamisligil G. S. RT Interaction between GATA and the C/EBP family of transcription factors is critical in GATA-mediated suppression of adipocyte differentiation. RL Mol. Cell. Biol. 25:706-715 (2005). RN [11]; RE0048127. RX PUBMED: 10411939. RA Zhang P., Behre G., Pan J., Iwama A., Wara-Aswapati N., Radomska H. S., Auron P. E., Tenen D. G., Sun Z. RT Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1. RL Proc. Natl. Acad. Sci. USA 96:8705-8710 (1999). RN [12]; RE0068516. RX PUBMED: 20833840. RA Maeda K., Nishiyama C., Ogawa H., Okumura K. RT GATA2 and Sp1 positively regulate the c-kit promoter in mast cells. RL J. Immunol. 185:4252-4260 (2010). XX //